Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE), Am Heart J. févr, vol.149, issue.2, pp.209-225, 2005. ,
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study, Eur J Heart Fail. 1 avr, vol.15, issue.4, pp.465-76, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00880093
Longterm trends in the incidence of and survival with heart failure, N Engl J Med, vol.347, issue.18, pp.1397-402, 2002. ,
,
ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, vol.128, issue.16, pp.240-327, 2013. ,
, , 2016.
, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J. 14 juill, vol.37, issue.27, pp.2129-200, 2016.
, Clinical epidemiology of heart failure. Heart. 1 sept, vol.93, issue.9, pp.1137-1183, 2007.
Managed care interventions for improving outcomes in acute heart failure syndromes, Am J Manag Care. déc, vol.14, issue.12, pp.287-291, 2008. ,
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine, Eur J Heart Fail. 1 mai, vol.12, issue.5, p.33, 2010. ,
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study, Eur J Heart Fail, vol.8, issue.7, p.705, 2006. ,
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF), Intensive Care Med. 1 avr, vol.37, issue.4, pp.619-645, 2011. ,
, EHFS II): a survey on hospitalized acute heart failure patients: description of population, EuroHeart Failure Survey II, vol.27, issue.22, pp.2725-2761, 2006.
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot), Eur J Heart Fail, vol.12, issue.10, pp.1076-84, 2010. ,
Prehospital and in-hospital course of care for patients with acute heart failure: Features and impact on prognosis in "real life, Arch Cardiovasc Dis. 1 févr, vol.110, issue.2, p.81, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01465814
Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure, JAMA, vol.296, issue.18, pp.2217-2243, 2006. ,
Outcome of heart failure with preserved ejection fraction in a population-based study, N Engl J Med. 20 juill, vol.355, issue.3, pp.260-269, 2006. ,
Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, Eur J Heart Fail. 1 déc, vol.12, issue.12, pp.643-651, 1997. ,
Preventable causative factors leading to hospital admission with decompensated heart failure. Heart Br Card Soc, vol.80, pp.437-478, 1998. ,
Acute precipitants of congestive heart failure exacerbations, Arch Intern Med, vol.161, pp.2337-2379, 2001. ,
,
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure, J Am Coll Cardiol, vol.42, issue.7, pp.1226-1259, 2003. ,
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail. janv, vol.13, issue.1, pp.1-10, 2011. ,
, Depression, antidepressants, and long-term mortality in heart failure, Int J Cardiol. 20 août, vol.167, issue.4, pp.1217-1242, 2013.
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database, Clin Res Cardiol Off J Ger Card Soc. déc, vol.33, issue.6, pp.1088-96, 2010. ,
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial, Eur J Heart Fail, vol.15, issue.11, pp.1267-76, 2013. ,
Renal dysfunction and heart failure: things are seldom what they seem, Eur Heart J. 14 févr, vol.35, issue.7, pp.416-424, 2014. ,
Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services, Eur Heart J. sept, vol.34, issue.36, pp.2795-803, 2013. ,
Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis, Clin Res Cardiol Off J Ger Card Soc. mars, vol.104, issue.3, pp.208-224, 2015. ,
Sleep disordered breathing and post-discharge mortality in patients with acute heart failure, Eur Heart J. 14 juin, vol.36, issue.23, pp.1463-1472, 2015. ,
DOI : 10.1093/eurheartj/ehu522
URL : https://academic.oup.com/eurheartj/article-pdf/36/23/1463/6732105/ehu522.pdf
The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea, 90. 31. guide_parcours_de_soins_ic_web.pdf, vol.22, p.20, 1999. ,
Usefulness of natriuretic peptide testing and Doppler ,
, Ann Cardiol Angeiol, vol.65, issue.5, pp.334-343, 2016.
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency, Ann Biol Clin, vol.71, issue.1, pp.1374-83, 2013. ,
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea, N Engl J Med. 12 févr, vol.350, issue.7, pp.647-54, 2004. ,
Prognostic markers of acute decompensated heart failure: the emerging roles of cardiac biomarkers and prognostic scores, Arch Cardiovasc Dis. janv, vol.108, issue.1, pp.64-74, 2015. ,
ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure, J Am Coll Cardiol. 15 mai, vol.49, p.50, 1943. ,
,
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure, J Am Coll Cardiol. 18 févr, vol.43, issue.4, pp.2117-2143, 2004. ,
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. avr, vol.29, issue.4, pp.277-314, 2016. ,
,
, Comparative Value of Doppler Echocardiography and B-Type Natriuretic Peptide Assay in the Etiologic Diagnosis of Acute Dyspnea, J Am Coll Cardiol, vol.40, p.800, 1794.
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea, Réanimation. 1 déc, vol.128, issue.1, p.30, 2005. ,
International evidence-based recommendations for point-of-care lung ultrasound, Intensive Care Med. avr, vol.38, issue.4, p.91, 2012. ,
Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol, Chest. juill, vol.134, issue.1, p.25, 2008. ,
A lung ultrasound sign allowing bedside distinction between pulmonary edema and COPD: the comet-tail artifact, Intensive Care Med. 1 déc, vol.24, issue.12, pp.1331-1335, 1998. ,
DOI : 10.1007/s001340050771
Combination of lung ultrasound (a comettail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting, Crit Care Lond Engl, vol.15, issue.2, p.114, 2011. ,
Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure, Am J Emerg Med. juin, vol.26, issue.5, pp.585-91, 2008. ,
A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial, Health Technol Assess Winch Engl. juill, vol.13, issue.33, pp.1-106, 2009. ,
Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema, N Engl J Med. 10 juill, vol.359, issue.2, p.51, 2008. ,
,
, Diuretic Strategies in Patients with Acute Decompensated Heart Failure, N Engl J Med. 3 mars, vol.364, issue.9, p.805, 2011.
,
CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS), dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE, vol.11, pp.293-302, 1987. ,
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure, Collaborative Group on ACE Inhibitor Trials. JAMA. 10 mai, vol.273, issue.18, pp.1450-1456, 1995. ,
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry, Eur J Heart Fail, vol.15, issue.10, pp.1173-84, 2013. ,
Effect of Carvedilol on Survival in Severe Chronic Heart Failure, N Engl J Med. 31 mai, vol.344, issue.22, pp.1651-1659, 2001. ,
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Wellbeing in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet Lond Engl. 2 janv, vol.283, issue.10, pp.9-13, 1999. ,
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med. 2 sept, vol.341, issue.10, pp.709-726, 1999. ,
,
, Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms, N Engl J Med. 6 janv, vol.364, issue.1, pp.11-21, 2011.
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. The Lancet. 6 sept, vol.362, pp.759-66, 2003. ,
Diuretics for heart failure, Cochrane Database Syst Rev. 15 févr, issue.2, p.3838, 2012. ,
,
, Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure, N Engl J Med. 11 sept, vol.371, issue.11, pp.993-1004, 2014.
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial, JAMA Cardiol. 1 janv, vol.2, issue.1, pp.79-85, 2017. ,
,
, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 11 sept, vol.376, p.85, 2010.
,
, Spironolactone for Heart Failure with Preserved Ejection Fraction, N Engl J Med. 10 avr, vol.370, issue.15, pp.1383-92, 2014.
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry, J Am Coll Cardiol. 21 août, vol.50, issue.8, pp.768-77, 2007. ,
ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and inhospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database, J Am Coll Cardiol. 3 janv, vol.47, issue.1, pp.76-84, 2006. ,
CardiacResynchronization Therapy in Heart Failure with a Narrow QRS Complex, N Engl J Med, vol.369, issue.15, pp.1395-405, 2013. ,
Éducation thérapeutique pour l'insuffisance cardiaque : une nécessité en, 2007. ,
A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure, N Engl J Med, vol.333, issue.18, pp.1190-1195, 1995. ,
The crucial role of patient education in heart failure, Eur J Heart Fail. 16 mars, vol.7, issue.3, pp.363-372, 2005. ,
Optimization of the management of acute heart failure ,
, Ann Cardiol Angeiol, vol.65, issue.5, p.3, 2016.
,
, Ann Cardiol Angeiol, vol.65, issue.5, pp.293-301, 2016.
, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'inter-viendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je donnerai mes soins à l'indigent et à quiconque me les demandera. Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses